Home/ Supplements/ Omega 3/ Clinical Metabolic Syndrome X Nutritiona...

Clinical Metabolic Syndrome X Nutritional Factors

product on market Capsule Natural Clinician Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 63% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains fish oil and green tea, which have moderate evidence for supporting lipid and metabolic health. Maitake mushroom and citrus bioflavonoids provide additional antioxidant properties, though evidence for their specific role in metabolic syndrome is more limited. The ingredient profile maintains a high safety score.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Clinical Metabolic Syndrome X Nutritional Factors
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
63%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
Maitake Mushroom
225 mg
Market median: 500.0mg (283 products) 174 studies (A:0, B:62)
150 mg
Market median: 260.0mg (249 products) 158 studies (A:4, B:61)
Oat Bran
150 mg
Berry Supreme Blend
150 mg
Cinnamon
100 mg
Kidney Bean Extract
75 mg
Market median: 200.0mg (198 products) 6 studies — no high-quality reviews
Market median: 450.0mg (167 products)
Market median: 250.0mg (182 products) 10 studies (A:0, B:2)
Market median: 100.0mg (284 products) 10 studies (A:0, B:4)
15 mg (100% DV)
1.4× RDA — within safe limits 263 studies (A:6, B:134)
2 mg (100% DV)
1.5× RDA — within safe limits 114 studies (A:3, B:35)
400 mcg (100% DV)
Within RDA (1.0× RDA) 226 studies (A:10, B:105)
360 mcg (300% DV)
10.3× RDA — above typical dose 199 studies (A:1, B:55)
300 mcg (100% DV)
10.0× RDA — above typical dose 27 studies (A:0, B:11)
15 mcg
Market median: 0.5mg (6 products) 1 studies (A:0, B:1)
6 mcg (100% DV)
2.5× RDA — within safe limits 139 studies (A:1, B:44)

Other Ingredients

All Natural Vegetable Source of
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

DIRECTIONS: Take one capsule three times daily with 4 oz. of pure water.

Additional Information

PATENT PENDING CLINICAL GRADE FORMULATION

Metadata

Product Details

UPC / SKU0 36733 00808 2
DSLD Entry Date2013-02-25
Product TypeOther Combinations
FormCapsule
DSLD ID18642
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.